Analyst Tazeen Ahmad works at BAML and is focused on the Healthcare sector with 191 price targets and ratings documented since 2014 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 63.76% with an average time for price targets to be met of 169.86 days.
Most recent stock forecast was given on PRLD, Prelude Therapeutics Inc. at 21-Nov-2022.
Tazeen Ahmad best performing recommendations are on GRTX (GALERA THERAPEUTICS INC.).
The best stock recommendation documented was for GRTX (GALERA THERAPEUTICS INC.) at 10/19/2021. The price target of $2 was fulfilled within 3 days with a profit of $0.25 (11.11%) receiving and performance score of 37.04.
Average potential price target upside
